© The International League Against Epilepsy
Edited By: Gary W. Mathern, MD and Astrid Nehlig, PhD
Impact Factor: 3.909
ISI Journal Citation Reports © Ranking: 2012: 33/193 (Clinical Neurology)
Online ISSN: 1528-1167
Controversy in Epilepsy
Read varying viewpoints on controversial issues in the field of epilepsy
In this edition of Epilepsia, we present a series of articles on the potential use of CBD and medical marijuana for epilepsy.
Addressing the need for the Wada test (intracarotid amobarbital procedure, IAP) and extraoperative language and motor mapping in patients who are undergoing epilepsy surgery. The question: Can some or all of these tests be abandoned in favor of less-invasive and sometimes lower cost techniques?